ANEMOCYTE

What this means for you

Not registered yet, but its 20 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79404747

Mark type

Word mark

Filed

20 Feb 2024

Attorney of record

Brian A. Tollefson

Goods and services

• Class 005 — Pharmaceuticals: Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines for dental purposes; chemical preparations for pharmaceutical or medical purposes, namely for oncology and immuno-oncology, respiratory, infectious diseases, flu, covid, cardiovascular, dermatology, rare diseases, metabolic diseases; biological preparations for the treatment of cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; biological reagents for medical purposes; vaccines; nucleic acid sequences for medical and veterinary products; dietetic foods adapted for medical use; antibodies for medical purposes; dietary supplements; pharmaceutical preparations for treating diabetes; diagnostic preparations for medical purposes; Biolofical tissue cultures fo rmedical use
• Class 010 — Medical apparatus: Medical instruments for cutting tissue; Surgical apparatus and instruments for medical, dental or veterinary use; Medical devices for use in treating or cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; Electro-surgical motors being part of surgical and medical apparatus and instruments for use in general surgery
• Class 042 — Scientific and technological services: Research and development of vaccines and medicines; scientific and technological services Scientific and technological services, namely manufacturing, scientific research, innovation and development, process development, analysis, testing, storage, stability studies, regulatory support in the field of cell and gene therapies, DNA and RNA; Research and development services in the field of medical preparations; medical research laboratories; design and development of computer hardware and computer software; scientific research; research and development services of new pharmaceutical products.

Owner

• ANEMOCYTE S.R.L., IT

Prosecution history

• 05 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 11 Dec 2025 — NOTIFICATION PROCESSED BY IB
• 03 Dec 2025 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
• 26 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 25 Nov 2025 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
• 25 Nov 2025 — WITHDRAWN FROM PUB - OG REVIEW QUERY
• 01 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 09 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 09 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 09 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 29 Dec 2024 — REFUSAL PROCESSED BY IB
• 09 Dec 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 09 Dec 2024 — REFUSAL PROCESSED BY MPU